Search research articles
Contact Us
Filters
Showing results (221-230 of 304) with videos related to
Page
of 31
Sort By:
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
|
October 17, 2017
Longitudinal outcomes of radiofrequency ablation versus surveillance endoscopy for Barrett's esophagus with low-grade dysplasia
A Kahn, M Al-Qaisi, V T Kommineni, et al.
American Journal of Preventive Medicine
|
April 3, 2017
Smoking-Cessation Assistance: Before and After Stage 1 Meaningful Use Implementation
Steffani R Bailey, John D Heintzman, Miguel Marino, et al.
Schizophrenia Research
|
December 2, 2008
Lack of an inverse relationship between duration of untreated psychosis and cognitive function in first episode schizophrenia
Terry E Goldberg, Katherine E Burdick, Joanne McCormack, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
November 7, 2014
Neurocognitive effects of ketamine and association with antidepressant response in individuals with treatment-resistant depression: a randomized controlled trial
James W Murrough, Katherine E Burdick, Cara F Levitch, et al.
Endoscopy
|
October 31, 2012
Prevalence of buried Barrett's metaplasia in patients before and after radiofrequency ablation
J Yuan, J C Hernandez, S K Ratuapli, et al.
Gastrointestinal Endoscopy
|
November 18, 2018
Intestinal metaplasia of the gastric cardia: findings in patients with versus without Barrett's esophagus
Hassan A Siddiki, Dora M Lam-Himlin, Allon Kahn, et al.
Archives of General Psychiatry
|
October 3, 2007
Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?
Terry E Goldberg, Robert S Goldman, Katherine E Burdick, et al.
Psychological Medicine
|
March 1, 2017
Characterizing cognitive heterogeneity on the schizophrenia-bipolar disorder spectrum
T E Van Rheenen, K E Lewandowski, E J Tan, et al.
Journal of Affective Disorders
|
May 9, 2025
BD<sup>2</sup>: A roadmap for learning health networks driving care improvement in bipolar disorder
Samuel T Savitz, Jessica M Lipschitz, Katherine E Burdick, et al.
Psychopharmacology
|
September 12, 2013
Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response
James W Murrough, Le-Ben Wan, Brian Iacoviello, et al.
Page
of 31
Search research articles
Search
Showing results (221-230 of 304) with videos related to
Sort By:
Page
of 31
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
|
October 17, 2017
Longitudinal outcomes of radiofrequency ablation versus surveillance endoscopy for Barrett's esophagus with low-grade dysplasia
A Kahn, M Al-Qaisi, V T Kommineni, et al.
American Journal of Preventive Medicine
|
April 3, 2017
Smoking-Cessation Assistance: Before and After Stage 1 Meaningful Use Implementation
Steffani R Bailey, John D Heintzman, Miguel Marino, et al.
Schizophrenia Research
|
December 2, 2008
Lack of an inverse relationship between duration of untreated psychosis and cognitive function in first episode schizophrenia
Terry E Goldberg, Katherine E Burdick, Joanne McCormack, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
November 7, 2014
Neurocognitive effects of ketamine and association with antidepressant response in individuals with treatment-resistant depression: a randomized controlled trial
James W Murrough, Katherine E Burdick, Cara F Levitch, et al.
Endoscopy
|
October 31, 2012
Prevalence of buried Barrett's metaplasia in patients before and after radiofrequency ablation
J Yuan, J C Hernandez, S K Ratuapli, et al.
Gastrointestinal Endoscopy
|
November 18, 2018
Intestinal metaplasia of the gastric cardia: findings in patients with versus without Barrett's esophagus
Hassan A Siddiki, Dora M Lam-Himlin, Allon Kahn, et al.
Archives of General Psychiatry
|
October 3, 2007
Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?
Terry E Goldberg, Robert S Goldman, Katherine E Burdick, et al.
Psychological Medicine
|
March 1, 2017
Characterizing cognitive heterogeneity on the schizophrenia-bipolar disorder spectrum
T E Van Rheenen, K E Lewandowski, E J Tan, et al.
Journal of Affective Disorders
|
May 9, 2025
BD<sup>2</sup>: A roadmap for learning health networks driving care improvement in bipolar disorder
Samuel T Savitz, Jessica M Lipschitz, Katherine E Burdick, et al.
Psychopharmacology
|
September 12, 2013
Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response
James W Murrough, Le-Ben Wan, Brian Iacoviello, et al.
Page
of 31